ConductScience.org, home

Paper24533232

Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.

Ngu SF and 1 other. Curr Obstet Gynecol Rep, 2014. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease. Papers, record 24533232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24533232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.
PubMed
Journal
Curr Obstet Gynecol Rep
PubMed
Year
2014
PubMed
Publication types
Review, Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2021-10-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ngu SFSiew-Fei
2Chan KKKaren K L

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119345988Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.Gynecol Oncol2009https://conductscience.org/library/papers/19345988PubMed
220660042Hyperglycosylated hCG is a marker of early human trophoblast invasion.J Clin Endocrinol Metab2010https://conductscience.org/library/papers/20660042PubMed
317711444EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients.Int J Gynecol Cancer2008https://conductscience.org/library/papers/17711444PubMed
415283048Inappropriate management of women with persistent low hCG results.J Reprod Med2004https://conductscience.org/library/papers/15283048PubMed
519822356Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.Gynecol Oncol2010https://conductscience.org/library/papers/19822356PubMed
615008778Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery.BJOG2004https://conductscience.org/library/papers/15008778PubMed
716631243Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.Gynecol Oncol2006https://conductscience.org/library/papers/16631243PubMed
822130490Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study.Lancet2012https://conductscience.org/library/papers/22130490PubMed
920619452Hyperglycosylated hCG, a review.Placenta2010https://conductscience.org/library/papers/20619452PubMed
1022455390hCG, the wonder of today's science.Reprod Biol Endocrinol2012https://conductscience.org/library/papers/22455390PubMed
1118708429Gestational trophoblastic disease: current management of hydatidiform mole.BMJ2008https://conductscience.org/library/papers/18708429PubMed
1217481633Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.Int J Gynaecol Obstet2007https://conductscience.org/library/papers/17481633PubMed
1312209690Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors.Cancer2002https://conductscience.org/library/papers/12209690PubMed
1419301571Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China.J Reprod Med2009https://conductscience.org/library/papers/19301571PubMed
1522449733Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.Gynecol Oncol2012https://conductscience.org/library/papers/22449733PubMed
1617977170Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor.J Reprod Med2007https://conductscience.org/library/papers/17977170PubMed
1711925147Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report.Gynecol Oncol2002https://conductscience.org/library/papers/11925147PubMed
1811919242Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.J Clin Oncol2002https://conductscience.org/library/papers/11919242PubMed
1921239399Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.Ann Oncol2011https://conductscience.org/library/papers/21239399PubMed
2012477450Role of hysterectomy in management of gestational trophoblastic disease.Gynecol Oncol2002https://conductscience.org/library/papers/12477450PubMed

See all 57 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42588652Persistent Low-Level hCG After Gestational Trophoblastic Neoplasia Remission: Treatment-Free Probability Stratified by Early hCG Course.Cancers (Basel)2026https://conductscience.org/library/papers/42588652PubMed
36936581Advances in the diagnosis and early management of gestational trophoblastic disease.BMJ Med2022https://conductscience.org/library/papers/36936581PubMed
34127641A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.Am J Case Rep2021https://conductscience.org/library/papers/34127641PubMed
33446242Hyperthyroidism in gestational trophoblastic disease - a literature review.Thyroid Res2021https://conductscience.org/library/papers/33446242PubMed
32509606A review on management of gestational trophoblastic neoplasia.J Family Med Prim Care2020https://conductscience.org/library/papers/32509606PubMed
32483804Evaluation of High-Dose Vitamin A Treatment in Postmolar Patients with Low and Plateauing Serum Human Chorionic Gonadotropin Levels.Rev Bras Ginecol Obstet2020https://conductscience.org/library/papers/32483804PubMed
31897223CD105 overexpression mediates drug-resistance in choriocarcinoma cells through BMP9/Smad pathway.J Cancer2020https://conductscience.org/library/papers/31897223PubMed
31489099Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute.Pan Afr Med J2019https://conductscience.org/library/papers/31489099PubMed
31337386Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report.BMC Womens Health2019https://conductscience.org/library/papers/31337386PubMed
31219560BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression.Carcinogenesis2020https://conductscience.org/library/papers/31219560PubMed
29367697Identification of microRNA signature in the progression of gestational trophoblastic disease.Cell Death Dis2018https://conductscience.org/library/papers/29367697PubMed
28653031The "hook effect" causing a negative pregnancy test in a patient with an advanced molar pregnancy.Gynecol Oncol Rep2017https://conductscience.org/library/papers/28653031PubMed
28116190Incidental Finding of Persistent Hydatidiform Mole in an Adolescent on Depo-Provera.Case Rep Obstet Gynecol2016https://conductscience.org/library/papers/28116190PubMed
27899973Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia.Oncol Lett2016https://conductscience.org/library/papers/27899973PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CGB593659PubTator's text mininghttps://conductscience.org/library/genes/93659

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24533232

GET https://conductscience.org/api/papers/v1/24533232/references?page=2